Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery
Natalia M. Fontecilla, BA,
Nicole W. Kittler, MD,
Larisa Geskin, MD,
Faramarz H. Samie, MD, PhD,
George Niedt, MD,
Thomas Imahiyerobo, MD,
Gary Schwartz, MD,
Matt Ingham, MD,
Jesse M. Lewin, MD
Affiliations
Natalia M. Fontecilla, BA
Columbia University College of Physicians and Surgeons, New York, New York
Nicole W. Kittler, MD
Department of Dermatology, Columbia University Medical Center, New York, New York
Larisa Geskin, MD
Department of Dermatology, Columbia University Medical Center, New York, New York
Faramarz H. Samie, MD, PhD
Department of Dermatology, Columbia University Medical Center, New York, New York
George Niedt, MD
Department of Dermatopathology, Columbia University Medical Center, New York, New York
Thomas Imahiyerobo, MD
Department of Plastic Surgery, Columbia University Medical Center, New York, New York
Gary Schwartz, MD
Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center, New York, New York
Matt Ingham, MD
Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center, New York, New York
Jesse M. Lewin, MD
Department of Dermatology, Columbia University Medical Center, New York, New York; Correspondence to: Jesse M. Lewin, MD, 161 Fort Washington Avenue, 12th floor, New York, NY 10032.